Curasight
Business Services · 1-10 Employees
View Company Info for Free
Overview
Phone Number
+45 22830160Website
www.curasight.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Curasight
Curasight is a Danish biotech company specializing in innovative cancer diagnosis and treatment through its novel uPAR Theranostics technology. The company focuses on improving cancer care by minimizing irradiation of healthy tissue with its targeted uTREAT radiation therapy and precise uTRACE diagnostics. Curasight aims to address the needs of cancer patients, particularly those with prostate and brain cancer, by developing more efficient and gentle treatment options. Their technology is currently undergoing several investigator-initiated phase II clinical trials to validate its effectiveness.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curasight your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Curasight launches new products
Funding: Get notified immidiatlly once Curasight has new funding data
Check out if Curasight is spiking on competitors!
Earning: See what the market has to say on Curasight recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Curasight
Check if Curasight has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Curasight had a recent Job posting/layoffs
Curasight, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Curasight
Find 3 more new buyers
Company Profile Activity
Activity Insights
Curasight is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curasight is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curasight.
Curasight Tech Stack
A closer look at the technologies used by Curasight
Curasight News & Media
Curasight to present at TD Cowen's 46th Annual Health Care Conference in Boston
COPENHAGEN, Denmark, Feb. 17, 2026 /PRNewswire/ -- Curasight A/S (CPH: CURAS) a clinical-stage radiopharmaceutical company pioneering first-in-class uPAR-targeted radioligand platform therapies across multiple aggressive solid tumors, will present recent company progress including the...Curasight to present at TD Cowen's 46th Annual Health Care Conference in Boston
COPENHAGEN, Denmark, Feb. 17, 2026 /PRNewswire/ -- Curasight A/S (CPH: CURAS) a clinical-stage radiopharmaceutical company pioneering first-in-class uPAR-targeted radioligand platform therapies across multiple aggressive solid tumors, will present recent company progress including the...Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
Clear uptake of uTREAT® in aggressive brain cancer (glioblastoma) Early data support the potential of first-in-class uPAR-targeted theranostic approach to enable more specific diagnosis and more targeted treatment of high-grade gliomas and other uPAR expressing aggressive solid tumors...Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
Clear uptake of uTREAT® in aggressive brain cancer (glioblastoma) Early data support the potential of first-in-class uPAR-targeted theranostic approach to enable more specific diagnosis and more targeted treatment of high-grade gliomas and other uPAR expressing aggressive solid tumors...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Curasight
Sign Up For FreeTo access detailed company insights
Curasight is a Danish biotech company specializing in innovative cancer diagnosis and treatment through its novel uPAR Theranostics technology. The company focuses on improving cancer care by minimizing irradiation of healthy tissue with its targeted uTREAT radiation therapy and precise uTRACE diagnostics. Curasight aims to address the needs of can... Read More
